Pandemic Preparedness Will Drive Next-Generation Vaccine Opportunities Amid Challenges
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
20 Aug 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$25.00
65.0% undervalued intrinsic discount20 Aug
US$8.74
1Y
-32.5%7D
-1.2%